Andrea Gombos

Statistics

Publications

Citations

639

H-Index

Active since

2019

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Inserm

Seoul National University Hospital

Memorial Sloan Kettering Cancer Center

Andrea Gombos is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in oncology, hormone receptor-positive breast cancer therapy, and hormone receptor - positive breast cancer.

Publications per year

2019–2025

Publications

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos et al. · The Lancet Oncology · 2019 · 477 citations

Medicine, Oncology, Pharmacology +14

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial

Shanu Modi, William Jacot, Hiroji Iwata et al. · Nature Medicine · 2025 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3